Literature DB >> 20177519

Lyme disease vaccine.

S A Halperin1.   

Abstract

Entities:  

Year:  2000        PMID： 20177519      PMCID： PMC2817792          DOI： 10.1093/pch/5.4.203

Source DB:  PubMed          Journal:  Paediatr Child Health        ISSN： 1205-7088            Impact factor:   2.253


× No keyword cloud information.
  11 in total

1.  Vector of Lyme borreliosis, Ixodes scapularis, identified in Saskatchewan.

Authors:  R Lindsay; H Artsob; T Galloway; G Horsman
Journal:  Can Commun Dis Rep       Date:  1999-05-01

2.  Consensus conference on Lyme disease.

Authors: 
Journal:  Can J Infect Dis       Date:  1991

3.  Isolation of Borrelia burgdorferi--Thunder Bay District, Ontario.

Authors:  S Banerjee; M Banerjee; J Scott; M Lankester; J Kubinec
Journal:  Can Commun Dis Rep       Date:  1996-08-15

4.  Distribution of Ixodes pacificus and Ixodes scapularis re concurrent babesiosis and Lyme disease.

Authors:  R Lindsay; H Artsob; I Barker
Journal:  Can Commun Dis Rep       Date:  1998-08-01

5.  Isolation of Borrelia burgdorferi on mainland Ontario.

Authors:  S N Banerjee; C I Christensen; J D Scott
Journal:  Can Commun Dis Rep       Date:  1995-05-30

6.  First isolation of Lyme disease spirochete, Borrelia burgdorferi, from blacklegged tick, Ixodes scapularis, removed from a bird in nova Scotia, Canada.

Authors:  M G Morshed; J D Scott; S N Banerjee; M Banerjee; T Fitzgerald; K Fernando; R Mann; J Isaac-Renton
Journal:  Can Commun Dis Rep       Date:  1999-09-15

7.  Recommendations for the use of Lyme disease vaccine. Recommendations of the Advisory Committee on Immunization Practices (ACIP)

Authors: 
Journal:  MMWR Recomm Rep       Date:  1999-06-04

Review 8.  Lyme borreliosis.

Authors:  R B Nadelman; G P Wormser
Journal:  Lancet       Date:  1998-08-15       Impact factor: 79.321

9.  The cost effectiveness of vaccinating against Lyme disease.

Authors:  M I Meltzer; D T Dennis; K A Orloski
Journal:  Emerg Infect Dis       Date:  1999 May-Jun       Impact factor: 6.883

10.  Vaccination against Lyme disease with recombinant Borrelia burgdorferi outer-surface lipoprotein A with adjuvant. Lyme Disease Vaccine Study Group.

Authors:  A C Steere; V K Sikand; F Meurice; D L Parenti; E Fikrig; R T Schoen; J Nowakowski; C H Schmid; S Laukamp; C Buscarino; D S Krause
Journal:  N Engl J Med       Date:  1998-07-23       Impact factor: 91.245
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.